Clinical and demographic characteristics of study participantsa.
| Group | n | Age | Height (cm) | Weight (kg) | BMI (kg m−2) |
|---|---|---|---|---|---|
| A (Female) | 6 | 27.8 ± 1.3 | 157.2 ± 3.1 | 55.3 ± 1.2 | 22.4 ± 1.0 |
| A (Male) | 6 | 27.5 ± 2.1 | 174.0 ± 4.3 | 68.2 ± 7.0 | 22.5 ± 2.1 |
| B (Female) | 6 | 27.0 ± 0.6 | 156.8 ± 2.9 | 53.7 ± 4.1 | 21.9 ± 1.9 |
| B (Male) | 6 | 27.2 ± 2.2 | 173.4 ± 4.1 | 66.2 ± 5.3 | 22.0 ± 1.7 |
a
All values are mean ± SDs; Group A, the subjects received RJ and ETRJ capsules; Group B, the subjects received two dose of ETRJ (800 mg and 1600 mg); BMI, body mass index; ETRJ, enzyme treated royal jelly; RJ, royal jelly.